SearchDictionaryMobileLogin

Sebastiano Cutrupi Selected Research

Chronic Kidney Failure (Chronic Renal Failure)

02/2008Urotensin II and Cardiomyopathy in End-Stage Renal Disease.
10/2006Low triiodothyronine and cardiomyopathy in patients with end-stage renal disease.
05/2006Urotensin II and biomarkers of endothelial activation and atherosclerosis in end-stage renal disease.
11/2005Urotensin II in end-stage renal disease: an inverse correlate of sympathetic function and cardiac natriuretic peptides.
09/2005Low triiodothyronine: a new facet of inflammation in end-stage renal disease.
06/2005Prognostic value of combined use of biomarkers of inflammation, endothelial dysfunction, and myocardiopathy in patients with ESRD.
01/2005Adipose tissue cytokines, insulin sensitivity, inflammation, and cardiovascular outcomes in end-stage renal disease patients.
10/2003Prospective study of neuropeptide y as an adverse cardiovascular risk factor in end-stage renal disease.
07/2003Neuropeptide Y, left ventricular mass and function in patients with end stage renal disease.
07/2002Norepinephrine and concentric hypertrophy in patients with end-stage renal disease.
03/2002Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease.
01/2002Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease.

Articles by Research Topic

Disease

12Chronic Kidney Failure (Chronic Renal Failure)
02/2008 - 01/2002
5Inflammation
03/2007 - 01/2005
3Cardiomyopathies (Cardiomyopathy)
02/2008 - 06/2005
1Left Ventricular Dysfunction
09/2008
1Kidney Diseases (Kidney Disease)
01/2008
1Infection
03/2007
1Hypothyroidism
02/2007
1Atherosclerosis (Atheroma)
05/2006
1Nephrotic Syndrome (Syndrome, Nephrotic)
05/2003
1Hypertension (High Blood Pressure)
09/2002
1Hypertrophy
07/2002

Drug/Important Bio-Agent (IBA)

3urotensin IIIBA
02/2008 - 11/2005
3AdiponectinIBA
05/2003 - 01/2002
2Triiodothyronine (Liothyronine)FDA Link
10/2006 - 09/2005
2Biological Markers (Surrogate Marker)IBA
05/2006 - 06/2005
2Neuropeptide YIBA
10/2003 - 07/2003
2Norepinephrine (Noradrenaline)FDA LinkGeneric
07/2002 - 03/2002
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2008
1Simvastatin (Zocor)FDA LinkGeneric
01/2008
1N,N-dimethylarginine (asymmetric dimethylarginine)IBA
01/2008
1Arginine (L-Arginine)FDA Link
03/2007
1Natriuretic PeptidesIBA
11/2005
1CytokinesIBA
01/2005
1Insulin (Novolin)FDA Link
01/2005

Therapy/Procedure

1Renal Dialysis (Hemodialysis)
09/2008
1Continuous Ambulatory Peritoneal Dialysis (CAPD)
02/2007